Lifeist Wellness Inc V.LFST

RE:RE:Growing $105 billion nutraceutical market in the U.S. alone

[20centsORLESS]

That's a copy paste... minimal spelling errors, other than where he tried to edit and lost some spacing... oh whisky, top notch posts!

randomtask wrote: You're putting a lot of pumping behind a product that you know absolutely nothing about... how many months behind do you think they will be?  The company needs about $5M per quarter of gross profit to breakeven from Mikra, which is at best $10M in sales.  That's a lot of fake wellness to sell.

whisky11 wrote:

Mikra’s CELLF will be available for prLifeist has now taken a major step in our transition to a portfolio of wellness companies,” said Meni Morim, Lifeist’s CEO. “Mikra is a breakthrough company seeking to unlock cellular potential and maximize the health of humans. With the launch of Mikra, Lifeist enlarges its total addressable market (TAM) to include the growing $105 billion nutraceutical market in the U.S. alone¹. We believe that Mikra will help consumers discover new pathways to individualized wellness whilst simultaneously rebuilding our shareholders’ value.”

 

Mikra Cellular Sciences Inc. (“Mikra”), is poised to launch its first product “CELLF”, a novel cellular therapeutic compound targeting systemic fatigue. As part of pre-launch activities of CELLF, Mikra has filed a patent application with the United States Patent and Trademark Office and partnered with InVivo Biosystems, Inc. (“InVivo Biosystems”) for pre-clinical trials to strengthen its patent claim.

 

“CELLF works at a cellular level to help combat systemic fatigue, inflammation, and brain fog by promoting the creation of mitochondria and subsequently increasing their efficiency. This is in addition to the upregulation and downregulation of certain cellular detoxification pathways that can remove the buildup of senescent (old/dysfunctional) cells that may cause excessive chronic inflammation and uncontrolled cell division.”

 

.CELLF will be shipped in a package containing 30 X 10ml single-serve sachets to prevent oxidation and maximize bioavailability.

 

Mikra has partnered with InVivo Biosystems, experts in genetic model creation and in vivo testing, to strengthen its patent application by conducting a pre-clinical study identifying genetic signatures and pathways associated with average human healthspans and to test the effects of CELLF on healthy aging.

e-sale in mid-Q1 2022 with a waitlist sign up available at www.wearemikra.com. CELLF will be available on www.wearemikra.com and Amazon following the pre-sale for full public launch.

 

https://lifeist.com/news/press-releases/press-releases-details/2021/Lifeist-Subsidiary-Mikra-Cellular-Sciences-to-Launch-First-Product-CELLF-to-Combat-Brain-Fog-and-Unlock-Healthy-Aging-Announces-U.S.-Patent-Application-and-Pre-Clinical-Study/default.aspx